Lisa Sher is a Managing Director at SternIR and has more than 15 years of experience in the healthcare sector. Prior to joining SternIR, Lisa served as a Senior Vice President at Argot Partners where she worked with public and private clients in multiple therapeutic areas including CNS, oncology, rare disease, and men’s and women’s health. Her clients ranged from preclinical to commercial stage.
Prior to Argot, Lisa had several years of experience as in-house head of investor relations for companies such as AC Immune, Opiant Pharmaceuticals and Aridis Pharmaceuticals. In those roles she was an integral part of large and small financings, crisis management, enhancing institutional ownership, broadening analyst coverage and investor relations and communications program planning and development.
Prior to these roles, Lisa served as Director, Investor Relations and Programming for the Biotechnology Innovation Organization (BIO) where she was the primary interface between the investment community and BIO. Lisa was integral in developing and planning all investor-driven events and creating new and innovative programs.
Lisa began her investor relations career at MBS Value Partners where she was instrumental in building its healthcare vertical.
Earlier in her career Lisa was a top-ranked pharmaceutical sales representative at Schering-Plough (acquired by Merck), Astra-Zeneca and Endo. She was an integral part of product launches and developing marketing materials and physician education programs.
In addition to her experience in the healthcare sector, Lisa loves the mountains and owned and operated a retail boutique in Aspen, Colorado. She enjoys skiing, hiking and playing golf.
Lisa holds a Bachelor of Arts in International Relations with honors from Boston University.